CDH2 and hepatocellular carcinoma: Furthermore, N-Cadherin expression has been extensively investigated in several other cancers (bladder, kidney clear cell, hepatocellular carcinoma, lung, ovarian, cervical squamous cell, and other cancers) and has been recognized as a negative prognostic factor [30].